Testing effectiveness (Phase 2)Study completedNCT00357396
What this trial is testing
Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors
Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 10